AG˹ٷ

STOCK TITAN

[Form 4] VolitionRX Limited Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

VolitionRX Limited director Ethel Rubin was awarded 17,424 restricted stock units (RSUs) on August 15, 2025 under the companys 2015 Stock Incentive Plan in lieu of cash compensation. The RSUs are earned in six approximately equal monthly installments beginning August 1, 2025, and once earned they remain subject to further time-based vesting in two equal installments of 8,712 units on each of November 1, 2025 and February 1, 2026. Vesting and settlement will deliver common stock equal to the number of RSUs earned and vested, and continued service is generally required through each applicable earning and vesting date. Following the award, the reporting person beneficially owns 62,948 shares. The Form 4 was signed by Ethel Rubin on August 19, 2025.

La direttrice di VolitionRX Limited, Ethel Rubin, ha ricevuto 17.424 unità azionarie vincolate (RSU) il 15 agosto 2025 ai sensi del Piano di Incentivazione Azionaria 2015 della società, in sostituzione della retribuzione in contanti. Le RSU vengono maturate in sei rate mensili approssimativamente uguali a partire dal 1° agosto 2025 e, una volta acquisite, sono soggette a un ulteriore periodo di vesting basato sul tempo in due rate uguali di 8.712 unità ciascuna, rispettivamente il 1° novembre 2025 e il 1° febbraio 2026. Il vesting e il regolamento comporteranno la consegna di azioni ordinarie pari al numero di RSU maturate e acquisite; in genere è richiesto il servizio continuativo fino a ciascuna data di maturazione e vesting. Dopo l'assegnazione, la persona segnalante detiene effettivamente 62.948 azioni. Il Modulo 4 è stato firmato da Ethel Rubin il 19 agosto 2025.

La directora de VolitionRX Limited, Ethel Rubin, recibió 17.424 unidades restringidas de acciones (RSU) el 15 de agosto de 2025 bajo el Plan de Incentivos sobre Acciones 2015 de la compañía en lugar de compensación en efectivo. Las RSU se devengan en seis pagos mensuales aproximadamente iguales a partir del 1 de agosto de 2025 y, una vez devengadas, quedan sujetas a una adjudicación adicional basada en el tiempo en dos pagos iguales de 8.712 unidades el 1 de noviembre de 2025 y el 1 de febrero de 2026. La consolidación y liquidación entregarán acciones ordinarias equivalentes al número de RSU devengadas y adjudicadas, y generalmente se requiere la permanencia en el cargo hasta cada fecha aplicable de devengo y adjudicación. Tras la adjudicación, la persona informante posee beneficiariamente 62.948 acciones. El Formulario 4 fue firmado por Ethel Rubin el 19 de agosto de 2025.

VolitionRX Limited� 이사 Ethel Rubin은 현금 보수 대� 2025� 8� 15� 회사� 2015 주식 인센티브 플랜� 따라 17,424개의 제한부 주식 단위(RSU)� 부여받았습니다. RSU� 2025� 8� 1일부� 시작� 대� 동일� 6회의 월별 분할� 획득되며, 획득� 후에� 추가적인 시간 기반 권리확정(vesting)� 2025� 11� 1일과 2026� 2� 1� 각각 8,712단위� � 번에 걸쳐 적용됩니�. 권리확정 � 정산 � 획득되고 권리확정� RSU 수와 동일� 수의 보통주가 지급되�, 일반적으� � 획득 � 권리확정일에 걸쳐 계속 근무해야 합니�. 부� 이후 보고인은 실질적으� 62,948주를 소유하고 있습니다. Form 4� 2025� 8� 19� Ethel Rubin� 서명했습니다.

La directrice de VolitionRX Limited, Ethel Rubin, s'est vu attribuer 17 424 unités d'actions restreintes (RSU) le 15 août 2025 en vertu du Plan d'incitation en actions 2015 de la société, en lieu et place d'une rémunération en espèces. Les RSU sont acquises en six versements mensuels à peu près égaux à partir du 1er août 2025 et, une fois acquises, elles restent soumises à un vesting temporel supplémentaire en deux versements égaux de 8 712 unités chacun, respectivement le 1er novembre 2025 et le 1er février 2026. Le vesting et le règlement donneront lieu à la livraison d'actions ordinaires égales au nombre de RSU acquises et vestées, et le maintien du service est généralement requis jusqu'à chacune des dates d'acquisition et de vesting applicables. Suite à l'attribution, la personne déclarée détient effectivement 62 948 actions. Le formulaire 4 a été signé par Ethel Rubin le 19 août 2025.

Die Direktorin von VolitionRX Limited, Ethel Rubin, erhielt am 15. August 2025 insgesamt 17.424 Restricted Stock Units (RSUs) im Rahmen des Aktienanreizplans 2015 des Unternehmens anstelle einer Barvergütung. Die RSUs werden in sechs etwa gleich großen monatlichen Raten beginnend am 1. August 2025 verdient und unterliegen, sobald sie verdient sind, einer weiteren zeitbasierten Vesting-Periode in zwei gleichen Raten von jeweils 8.712 Einheiten am 1. November 2025 und am 1. Februar 2026. Das Vesting und die Abwicklung führen zur Lieferung von Stammaktien in Höhe der Anzahl der verdienten und vested RSUs; normalerweise ist für jedes relevante Earn- und Vesting-Datum eine fortgesetzte Dienstzeit erforderlich. Nach der Zuteilung besitzt die meldende Person wirtschaftlich 62.948 Aktien. Das Formular 4 wurde am 19. August 2025 von Ethel Rubin unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director compensation awarded as RSUs aligns pay with shareholder outcomes and ties retention to service-based vesting.

The award of 17,424 RSUs in lieu of cash is a common governance practice to align a directors interests with shareholders and to conserve cash. The structuresix monthly earning installments followed by two time-based vesting datescreates both near-term earning and multi-month retention incentives. This is routine for board compensation and does not on its face indicate governance concerns; materiality is limited given the size of the award relative to the companys outstanding shares (not disclosed here).

TL;DR: RSUs convert to common stock upon vesting, causing potential dilution when settled; timing is defined but dollar impact is unspecified.

The filing clearly states the RSUs will settle into common shares equal to vested units, which will increase outstanding share count upon settlement. The award replaces cash compensation, so immediate cash outflow is avoided. Because the filing does not disclose the total share base or percentage dilution, the economic impact cannot be quantified from this form alone.

La direttrice di VolitionRX Limited, Ethel Rubin, ha ricevuto 17.424 unità azionarie vincolate (RSU) il 15 agosto 2025 ai sensi del Piano di Incentivazione Azionaria 2015 della società, in sostituzione della retribuzione in contanti. Le RSU vengono maturate in sei rate mensili approssimativamente uguali a partire dal 1° agosto 2025 e, una volta acquisite, sono soggette a un ulteriore periodo di vesting basato sul tempo in due rate uguali di 8.712 unità ciascuna, rispettivamente il 1° novembre 2025 e il 1° febbraio 2026. Il vesting e il regolamento comporteranno la consegna di azioni ordinarie pari al numero di RSU maturate e acquisite; in genere è richiesto il servizio continuativo fino a ciascuna data di maturazione e vesting. Dopo l'assegnazione, la persona segnalante detiene effettivamente 62.948 azioni. Il Modulo 4 è stato firmato da Ethel Rubin il 19 agosto 2025.

La directora de VolitionRX Limited, Ethel Rubin, recibió 17.424 unidades restringidas de acciones (RSU) el 15 de agosto de 2025 bajo el Plan de Incentivos sobre Acciones 2015 de la compañía en lugar de compensación en efectivo. Las RSU se devengan en seis pagos mensuales aproximadamente iguales a partir del 1 de agosto de 2025 y, una vez devengadas, quedan sujetas a una adjudicación adicional basada en el tiempo en dos pagos iguales de 8.712 unidades el 1 de noviembre de 2025 y el 1 de febrero de 2026. La consolidación y liquidación entregarán acciones ordinarias equivalentes al número de RSU devengadas y adjudicadas, y generalmente se requiere la permanencia en el cargo hasta cada fecha aplicable de devengo y adjudicación. Tras la adjudicación, la persona informante posee beneficiariamente 62.948 acciones. El Formulario 4 fue firmado por Ethel Rubin el 19 de agosto de 2025.

VolitionRX Limited� 이사 Ethel Rubin은 현금 보수 대� 2025� 8� 15� 회사� 2015 주식 인센티브 플랜� 따라 17,424개의 제한부 주식 단위(RSU)� 부여받았습니다. RSU� 2025� 8� 1일부� 시작� 대� 동일� 6회의 월별 분할� 획득되며, 획득� 후에� 추가적인 시간 기반 권리확정(vesting)� 2025� 11� 1일과 2026� 2� 1� 각각 8,712단위� � 번에 걸쳐 적용됩니�. 권리확정 � 정산 � 획득되고 권리확정� RSU 수와 동일� 수의 보통주가 지급되�, 일반적으� � 획득 � 권리확정일에 걸쳐 계속 근무해야 합니�. 부� 이후 보고인은 실질적으� 62,948주를 소유하고 있습니다. Form 4� 2025� 8� 19� Ethel Rubin� 서명했습니다.

La directrice de VolitionRX Limited, Ethel Rubin, s'est vu attribuer 17 424 unités d'actions restreintes (RSU) le 15 août 2025 en vertu du Plan d'incitation en actions 2015 de la société, en lieu et place d'une rémunération en espèces. Les RSU sont acquises en six versements mensuels à peu près égaux à partir du 1er août 2025 et, une fois acquises, elles restent soumises à un vesting temporel supplémentaire en deux versements égaux de 8 712 unités chacun, respectivement le 1er novembre 2025 et le 1er février 2026. Le vesting et le règlement donneront lieu à la livraison d'actions ordinaires égales au nombre de RSU acquises et vestées, et le maintien du service est généralement requis jusqu'à chacune des dates d'acquisition et de vesting applicables. Suite à l'attribution, la personne déclarée détient effectivement 62 948 actions. Le formulaire 4 a été signé par Ethel Rubin le 19 août 2025.

Die Direktorin von VolitionRX Limited, Ethel Rubin, erhielt am 15. August 2025 insgesamt 17.424 Restricted Stock Units (RSUs) im Rahmen des Aktienanreizplans 2015 des Unternehmens anstelle einer Barvergütung. Die RSUs werden in sechs etwa gleich großen monatlichen Raten beginnend am 1. August 2025 verdient und unterliegen, sobald sie verdient sind, einer weiteren zeitbasierten Vesting-Periode in zwei gleichen Raten von jeweils 8.712 Einheiten am 1. November 2025 und am 1. Februar 2026. Das Vesting und die Abwicklung führen zur Lieferung von Stammaktien in Höhe der Anzahl der verdienten und vested RSUs; normalerweise ist für jedes relevante Earn- und Vesting-Datum eine fortgesetzte Dienstzeit erforderlich. Nach der Zuteilung besitzt die meldende Person wirtschaftlich 62.948 Aktien. Das Formular 4 wurde am 19. August 2025 von Ethel Rubin unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rubin Ethel

(Last) (First) (Middle)
1489 WEST WARM SPRINGS ROAD,
SUITE 110

(Street)
HENDERSON NV 89014

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 A 17,424(1) A $0 62,948 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On August 15, 2025, the reporting person was awarded 17,424 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs are earned in six approximately equal monthly installments commencing on August 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 8,712 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.
Remarks:
/s/ Ethel Rubin 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Volitionrx

NYSE:VNRX

VNRX Rankings

VNRX Latest News

VNRX Latest SEC Filings

VNRX Stock Data

65.74M
86.71M
17.84%
22.29%
0.18%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
United States
HENDERSON